Cargando…
Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy
BACKGROUND: People with HIV (PWH) on antiretroviral therapy (ART) still experience an increased risk of morbidity and mortality, presumably driven by chronic inflammation, yet predictors of discrete or combinatorial outcomes remain unclear. Galectin-9 (Gal-9), a driver of both inflammatory and immun...
Autores principales: | Premeaux, Thomas A., Moser, Carlee B., McKhann, Ashley, Hoenigl, Martin, Laws, Elizabeth I., Aquino, Draven L., Lederman, Michael M., Landay, Alan L., Gianella, Sara, Ndhlovu, Lishomwa C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631144/ https://www.ncbi.nlm.nih.gov/pubmed/34366381 http://dx.doi.org/10.1097/QAD.0000000000003048 |
Ejemplares similares
-
Monitoring Circulating Immune Checkpoint Proteins as Predictors of Non-AIDS Morbid Events in People With HIV Initiating Antiretroviral Therapy
por: Premeaux, Thomas A, et al.
Publicado: (2022) -
Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection
por: Yeung, Stephen T., et al.
Publicado: (2022) -
Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK Signaling
por: Colomb, Florent, et al.
Publicado: (2019) -
The latent HIV reservoir: current advances in genetic sequencing approaches
por: Moar, Preeti, et al.
Publicado: (2023) -
Role of Natural Killer Cells in HIV-Associated Malignancies
por: Leal, Fabio E., et al.
Publicado: (2017)